Isosorbide mononitrate and Psoriasis - a phase IV clinical study of FDA data

Summary:

Psoriasis is found among people who take Isosorbide mononitrate, especially for people who are male, 50-59 old.

The phase IV clinical study analyzes which people take Isosorbide mononitrate and have Psoriasis. It is created by eHealthMe based on reports of 23,163 people who have side effects when taking Isosorbide mononitrate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 25, 2022

23,163 people reported to have side effects when taking Isosorbide mononitrate.
Among them, 109 people (0.47%) have Psoriasis.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 23,548 Isosorbide mononitrate users for its effectiveness, alternative drugs and more.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 2,274 drugs and 1,581 conditions by eHealthMe.

Number of Isosorbide mononitrate and Psoriasis reports submitted per year:

Could Isosorbide mononitrate cause Psoriasis?

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide mononitrate and have Psoriasis?

Check whether Psoriasis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .

Related studies

How severe was Psoriasis and when was it recovered:

Psoriasis in Isosorbide mononitrate

Expand to all the drugs that have ingredients of isosorbide mononitrate:

Psoriasis and drugs with ingredients of isosorbide mononitrate (170 reports)

Alternative drugs to, pros and cons of Isosorbide mononitrate:

Isosorbide mononitrate (23,548 reports)

Common Isosorbide mononitrate side effects:

Hypotension (abnormally low blood pressure): 1,411 reports
Chest pain: 1,367 reports
Breathing difficulty: 1,271 reports
Dizziness: 1,227 reports
Fatigue (feeling of tiredness): 1,133 reports
Diarrhea: 1,076 reports

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Psoriasis treatments and more:

Psoriasis (412,216 reports)

COVID vaccines that are related to Psoriasis:

Common drugs associated with Psoriasis:

All the drugs that are associated with Psoriasis:

Psoriasis (2,274 drugs)

Common conditions associated with Psoriasis:

Rheumatoid arthritis: 6,377 reports
High blood pressure: 3,552 reports
Crohn's disease: 3,134 reports
Pain: 1,905 reports

All the conditions that are associated with Psoriasis:

Psoriasis (1,581 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate (the active ingredients of Isosorbide mononitrate) and Isosorbide mononitrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.